Effectiveness of eHealth on the Self-management of Health Status and QOL Among CAD Patients

March 1, 2021 updated by: Hui-Hsun Chiang, National Defense Medical Center, Taiwan

Effectiveness of eHealth on the Self-management, Physiological Health and Quality of Life Among Coronary Artery Disease Patients

This article uses the smart medical case management tracking system, combined with various terminal devices to fully record the measured data (pulse, blood pressure) for case home care tracking to prevent the occurrence and deterioration of the disease. Therefore, with the promotion of the eHealth medical staff and members of the family can instantly grasp the health of the body and cultivate the habits of self-health management and enhance the quality of care. Therefore, we hope to use the Smart Health Cloud as an interventional measure to improve the care of patients with coronary artery disease, improve self-management ability and quality of life.

Study Overview

Detailed Description

The World Health Organization points out that cardiovascular disease is the number one killer of global deaths, killing 17.1 million people worldwide each year, accounting for 31% of the world's total deaths. Heart disease is the second leading cause of death in China. Coronary artery disease (CAD) is the majority, and coronary artery disease is the most common cardiovascular disease. Good self-management can reduce disease risk factors and improve related prognosis. It is also an important issue in health promotion around the world. This article uses the smart medical case management tracking system, combined with various terminal devices to fully record the measured data (pulse, blood pressure) for case home care tracking to prevent the occurrence and deterioration of the disease. Therefore, with the promotion of the eHealth medical staff and members of the family can instantly grasp the health of the body and cultivate the habits of self-health management and enhance the quality of care. Therefore, we hope to use the Smart Health Cloud as an interventional measure to improve the care of patients with coronary artery disease, improve self-management ability and quality of life.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei city, Taiwan
        • TSGH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • A patient who is 20 years of age or older and has a Coronary computed tomography angiography >50% vascular stenosis, has been PTCA、stent or CABG
  • Taiwanese, understand Chinese

Exclusion Criteria:

  • Those who can't express their wishes clearly (such as Azheimer's disease, mental dysfunction)
  • mental disorder
  • infectious diseases
  • Patients who participate in other research projects

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: eHealth
Provide home physiology measurement services, including automatic uploading of measured blood pressure values to the cloud, serial back-end education platform to provide numerical anomaly alarms and health care notifications, monthly measurement data reports, combined with mobile APP management system for immediate enquiry . In addition to the electric visit to the patient's health education guidance, the content includes: 1. Encourage the walking exercise to perform 2. Ask the walking exercise execution progress, please return the daily value of the case to facilitate the record 3. Answer the relevant questions asked during the intervention.
The study was randomized (wait-list-control), and it was estimated that 60 subjects were randomly assigned to the immediate treatment group and the wait-list-control group. The two groups were tested for baseline before intervention in the eHealth. After the first questionnaire evaluation, the experimental group was involved in the eHealth for three months, and after three months, the experimental group and the waiting intervention control group were post-tested. To assess the effectiveness of the two groups before and after the eHealth . Control group that waits for intervention in the fourth month from the beginning of the fourth month to the end of the sixth month
Experimental: wait list control
wait list control for 3 months and then Provide home physiology measurement services, including automatic uploading of measured blood pressure values to the cloud, serial back-end education platform to provide numerical anomaly alarms and health care notifications, monthly measurement data reports, combined with mobile APP management system for immediate enquiry . In addition to the electric visit to the patient's health education guidance, the content includes: 1. Encourage the walking exercise to perform 2. Ask the walking exercise execution progress, please return the daily value of the case to facilitate the record 3. Answer the relevant questions asked during the intervention.
The study was randomized (wait-list-control), and it was estimated that 60 subjects were randomly assigned to the immediate treatment group and the wait-list-control group. The two groups were tested for baseline before intervention in the eHealth. After the first questionnaire evaluation, the experimental group was involved in the eHealth for three months, and after three months, the experimental group and the waiting intervention control group were post-tested. To assess the effectiveness of the two groups before and after the eHealth . Control group that waits for intervention in the fourth month from the beginning of the fourth month to the end of the sixth month

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
physiological indicators-HDL-C(T1)
Time Frame: T1-baseline
HDL-C, the unit is mg/dL
T1-baseline
physiological indicators-HDL-C(T2)
Time Frame: T2-three months later
HDL-C, the unit is mg/dL
T2-three months later
physiological indicators-HDL-C(T3)
Time Frame: T3-six months later
HDL-C, the unit is mg/dL
T3-six months later
physiological indicators-LDL-C(T1)
Time Frame: T1-baseline
LDL-C, the unit is mg/dL
T1-baseline
physiological indicators-LDL-C(T2)
Time Frame: T2-three months later
LDL-C, the unit is mg/dL
T2-three months later
physiological indicators-LDL-C(T3)
Time Frame: T3-six months later
LDL-C, the unit is mg/dL
T3-six months later
physiological indicators-Total Cholesterol(T1)
Time Frame: T1-baseline
Total Cholesterol, the unit is mg/dL
T1-baseline
physiological indicators-Total Cholesterol(T2)
Time Frame: T2-three months later
Total Cholesterol, the unit is mg/dL
T2-three months later
physiological indicators-Total Cholesterol(T3)
Time Frame: T3-six months later
Total Cholesterol, the unit is mg/dL
T3-six months later
physiological indicators-Triglyceride(T1)
Time Frame: T1-baseline
Triglyceride, the unit is mg/dL
T1-baseline
physiological indicators-Triglyceride(T2)
Time Frame: T2-three months later
Triglyceride, the unit is mg/dL
T2-three months later
physiological indicators-Triglyceride(T3)
Time Frame: T3-six months later
Triglyceride, the unit is mg/dL
T3-six months later
physiological indicators-GLU(T1)
Time Frame: T1-baseline
GLU, the unit is mg/dL
T1-baseline
physiological indicators-GLU(T2)
Time Frame: T2-three months later
GLU, the unit is mg/dL
T2-three months later
physiological indicators-GLU(T3)
Time Frame: T3-six months later
GLU, the unit is mg/dL
T3-six months later
physiological indicators-HbA1C(T1)
Time Frame: T1-baseline
HbA1C, the unit is %
T1-baseline
physiological indicators-HbA1C(T2)
Time Frame: T2-three months later
HbA1C, the unit is %
T2-three months later
physiological indicators-HbA1C(T3)
Time Frame: T3-six months later
HbA1C, the unit is %
T3-six months later

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
self-management-T1
Time Frame: T1-baseline
use The partners in Health scale. total of 12 questions,The scoring method uses the nine-point Likert Scales score. The score of 0 is divided into self-management performance, and the score of 8 indicates that self-management is good. The total score is 96 points. The higher the score, the better the self-management.
T1-baseline
self-management-T2
Time Frame: T2-three months later
use The partners in Health scale. total of 12 questions,The scoring method uses the nine-point Likert Scales score. The score of 0 is divided into self-management performance, and the score of 8 indicates that self-management is good. The total score is 96 points. The higher the score, the better the self-management.
T2-three months later
self-management-T3
Time Frame: T3-six months later
use The partners in Health scale. total of 12 questions,The scoring method uses the nine-point Likert Scales score. The score of 0 is divided into self-management performance, and the score of 8 indicates that self-management is good. The total score is 96 points. The higher the score, the better the self-management.
T3-six months later

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life scale-T1
Time Frame: T1-baseline
use WHOQOL-BREF Taiwan Version. total of 28 questions,The scoring method uses the five-point Likert Scales score The questionnaire has a total of 28 questions, with at least one point for each question and a maximum of five points. The higher the score, the better the quality of life.
T1-baseline
Quality of life scale-T2
Time Frame: T2-three months later
use WHOQOL-BREF Taiwan Version. total of 28 questions,The scoring method uses the five-point Likert Scales score The questionnaire has a total of 28 questions, with at least one point for each question and a maximum of five points. The higher the score, the better the quality of life.
T2-three months later
Quality of life scale-T3
Time Frame: T3-six months later
use WHOQOL-BREF Taiwan Version. total of 28 questions,The scoring method uses the five-point Likert Scales score The questionnaire has a total of 28 questions, with at least one point for each question and a maximum of five points. The higher the score, the better the quality of life.
T3-six months later
Modified Health care machine rating scale
Time Frame: T2-three months later
There are three questions in the satisfaction survey. Use category options to measure usage satisfaction
T2-three months later

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 18, 2019

Primary Completion (Actual)

July 15, 2020

Study Completion (Actual)

October 5, 2020

Study Registration Dates

First Submitted

October 22, 2019

First Submitted That Met QC Criteria

October 29, 2019

First Posted (Actual)

October 31, 2019

Study Record Updates

Last Update Posted (Actual)

March 3, 2021

Last Update Submitted That Met QC Criteria

March 1, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Disease

Clinical Trials on eHealth

Subscribe